Search Records

Health Canada has answered questions about access to controlled substances at the federal, provincial and territorial government levels. The answers may help health care providers better understand care options during the COVID-19 pandemic for patients who use drugs.

High-level description of when patients, practitioners and pharmacists are exempt from some sections of the Controlled Drugs and Substances Act during the COVID-19 (coronavirus) pandemic.

This toolkit provides information to support health care providers to understand their options in providing care for their patients who use drugs during the pandemic.

Targeted actions to reduce the risk of harm for people who use substances during the pandemic.

Between 2018 and 2020, Health Canada has issued a number of exemptions to the Controlled Drugs and Substances Act. Some of the exemptions have been issued to maintain Canadians' access to controlled substances during the COVID-19 pandemic.

Supportive online resources to help with pain management during COVID-19.

Health Canada is taking urgent measures to protect consumers from illegal, false or misleading advertising of products claiming to mitigate, prevent, treat, diagnose, or cure COVID-19.

This notice outlines the safety and effectiveness requirements for closed system devices that decontaminate medical devices using ultraviolet (UV) radiation. The notice is for manufacturers using an interim order (IO) authorization or medical device licence application.

Whereas the Minister of Health believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment; the Minister of Health, pursuant to subsection 30.1‍(1)Footnote 1 of the Food and Drugs ActFootnote 2, makes the annexed Interim...

Whereas the Minister of Health believes that immediate action is required to deal with a significant risk, direct or indirect, to health, safety or the environment; the Minister of Health, pursuant to subsection 30.1‍(1)Footnote 1 of the Food and Drugs ActFootnote 2, makes the annexed Interim...